Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-14 4:32 pm Sale | 2021-12-31 | 13G | Bellicum Pharmaceuticals, Inc. BLCM | Ikarian Capital, LLC | 496,756 5.900% | -3,244 (-0.65%) | Filing History |
| 2022-02-14 4:32 pm Sale | 2021-12-31 | 13G | KalVista Pharmaceuticals, Inc. KALV | Ikarian Capital, LLC | 36,576 0.200% | -1,027,385 (-96.56%) | Filing History |
| 2022-02-14 4:31 pm Sale | 2021-12-31 | 13G | Millendo Therapeutics, Inc. MLND | Ikarian Capital, LLC | 58,803 0.900% | -31,065 (-34.57%) | Filing History |
| 2022-02-14 4:30 pm Sale | 2021-12-31 | 13G | Lyra Therapeutics, Inc. LYRA | Ikarian Capital, LLC | 7,891 3.000% | -8,417 (-51.61%) | Filing History |
| 2021-09-17 3:00 pm Purchase | 2021-09-16 | 13G | aTyr Pharma, Inc. ATYR | Ikarian Capital, LLC | 888,580 5.300% | 888,580 (New Position) | Filing History |
| 2021-07-02 4:05 pm Purchase | 2021-06-11 | 13G | Odonate Therapeutics, Inc. ODTC | Ikarian Capital, LLC | 0 5.200% | 0 (New Position) | Filing History |
| 2021-04-08 09:02 am Purchase | 2021-03-23 | 13G | X4 Pharmaceuticals, Inc. XFOR | Ikarian Capital, LLC | 87,500 11.100% | 59,952 (+217.63%) | Filing History |
| 2021-04-07 5:25 pm Purchase | 2021-03-18 | 13G | Millendo Therapeutics, Inc. MLND | Ikarian Capital, LLC | 89,868 7.100% | 89,868 (New Position) | Filing History |
| 2021-02-16 08:33 am Purchase | 2020-12-31 | 13G | TRACON Pharmaceuticals, Inc. TCON | Ikarian Capital, LLC | 135,842 17.800% | 27,715 (+25.63%) | Filing History |
| 2021-02-16 08:31 am Purchase | 2020-12-31 | 13G | KalVista Pharmaceuticals, Inc. KALV | Ikarian Capital, LLC | 1,063,961 5.900% | 117,356 (+12.40%) | Filing History |
| 2021-02-16 07:49 am Purchase | 2020-12-31 | 13G | Lyra Therapeutics, Inc. LYRA | Ikarian Capital, LLC | 16,307 6.300% | 600 (+3.82%) | Filing History |
| 2021-02-12 4:35 pm Purchase | 2020-12-31 | 13G | scPharmaceuticals Inc. SCPH | Ikarian Capital, LLC | 1,466,147 5.400% | 392,500 (+36.56%) | Filing History |
| 2021-02-12 4:32 pm Sale | 2020-12-31 | 13G | Celldex Therapeutics, Inc. CLDX | Ikarian Capital, LLC | 1,364,990 3.500% | -227,449 (-14.28%) | Filing History |
| 2021-02-12 4:32 pm Sale | 2020-12-31 | 13G | Strongbridge Biopharma plc SBBP | Ikarian Capital, LLC | 2,440,028 3.600% | -802,759 (-24.76%) | Filing History |
| 2021-02-12 4:31 pm Purchase | 2020-12-31 | 13G | KINETA INC KANT | Ikarian Capital, LLC | 132,514 1.300% | 132,514 (New Position) | Filing History |
| 2021-02-12 4:31 pm Sale | 2020-12-31 | 13G | Verastem, Inc. VSTM | Ikarian Capital, LLC | 187,883 1.300% | -233,107 (-55.37%) | Filing History |
| 2021-02-12 4:31 pm Purchase | 2020-12-31 | 13G | Protara Therapeutics, Inc. TARA | Ikarian Capital, LLC | 649,542 5.800% | 649,542 (New Position) | Filing History |
| 2021-01-11 5:25 pm Purchase | 2020-08-03 | 13G | Milestone Pharmaceuticals Inc. MIST | Ikarian Capital, LLC | 1,836,545 6.200% | 1,836,545 (New Position) | Filing History |
| 2021-01-11 5:24 pm Purchase | 2020-11-24 | 13G | LifeSci Acquisition II Corp. LSAQ | Ikarian Capital, LLC | 512,450 6.400% | 512,450 (New Position) | Filing History |
| 2021-01-08 9:59 pm Purchase | 2020-12-23 | 13G | Cyclacel Pharmaceuticals, Inc. CYCC | Ikarian Capital, LLC | 111 8.200% | 111 (New Position) | Filing History |